GlassScriptPhysician profile
Cara Tokorcheck
NPI 1033720560
$2,912.01
in general payments reported to CMS, 2019-2025
30 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $939 · 2022: $1,265 · 2023: $205 · 2024: $291 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $909.30 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $276.01 | 2021-2022 | |
| Amgen INC. | $246.67 | 2021-2022 | |
| Sk Life Science, INC. | $177.07 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $137.83 | 2021-2023 | |
| Boston Scientific Corporation | $130.15 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $108.94 | 2021-2022 | |
| Horizon Therapeutics Plc | $81.78 | 2021-2022 | |
| Genentech USA, INC. | $78.71 | 2021-2025 | Ocrevus Zunovo, Ocrevus |
| Biogen, INC. | $77.72 | 2022 | |
| Ucb, INC. | $77.49 | 2021-2022 | |
| Csl Behring | $72.30 | 2021-2023 | Hizentra |
| Lundbeck LLC | $71.23 | 2021 | |
| Ge Healthcare | $53.92 | 2021-2022 | |
| Acorda Therapeutics, INC | $51.17 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $41.28 | 2022 | |
| Alexion Pharmaceuticals, INC. | $39.81 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $33.80 | 2021 | |
| Merck Sharp & Dohme LLC | $30.67 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $29.85 | 2022 | |
| Merz Pharmaceuticals, LLC | $26.86 | 2022 | |
| Medtronic, INC. | $23.03 | 2024 | Activa PC |
| Eisai INC. | $22.12 | 2021 | |
| Acadia Pharmaceuticals INC | $20.23 | 2022 | |
| Pfizer INC. | $18.11 | 2022 | |
| Amneal Pharmaceuticals LLC | $17.17 | 2021 | |
| Kyowa Kirin, INC. | $16.97 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.11 | 2022 | |
| Lilly USA, LLC | $14.90 | 2022 | |
| Currax Pharmaceuticals LLC | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Tokorcheck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.